Ananthaswamy HN - Search Results

1

p53 and the pathogenesis of skin cancer.

Benjamin CL, Ananthaswamy HN. Benjamin CL, et al. Among authors: ananthaswamy hn. Toxicol Appl Pharmacol. 2007 Nov 1;224(3):241-8. doi: 10.1016/j.taap.2006.12.006. Epub 2006 Dec 15. Toxicol Appl Pharmacol. 2007. PMID: 17270229 Free PMC article. Review.

2

Models and mechanisms in malignant melanoma.

Benjamin CL, Melnikova VO, Ananthaswamy HN. Benjamin CL, et al. Among authors: ananthaswamy hn. Mol Carcinog. 2007 Aug;46(8):671-8. doi: 10.1002/mc.20353. Mol Carcinog. 2007. PMID: 17570501 Review.

3

p53 tumor suppressor gene: a critical molecular target for UV induction and prevention of skin cancer.

Benjamin CL, Ullrich SE, Kripke ML, Ananthaswamy HN. Benjamin CL, et al. Among authors: ananthaswamy hn. Photochem Photobiol. 2008 Jan-Feb;84(1):55-62. doi: 10.1111/j.1751-1097.2007.00213.x. Photochem Photobiol. 2008. PMID: 18173701 Review.

4

P53 protein and pathogenesis of melanoma and nonmelanoma skin cancer.

Benjamin CL, Melnikova VO, Ananthaswamy HN. Benjamin CL, et al. Among authors: ananthaswamy hn. Adv Exp Med Biol. 2008;624:265-82. doi: 10.1007/978-0-387-77574-6_21. Adv Exp Med Biol. 2008. PMID: 18348463 Review.

5

Absence of p53-dependent apoptosis leads to UV radiation hypersensitivity, enhanced immunosuppression and cellular senescence.

Tavana O, Benjamin CL, Puebla-Osorio N, Sang M, Ullrich SE, Ananthaswamy HN, Zhu C. Tavana O, et al. Among authors: ananthaswamy hn. Cell Cycle. 2010 Aug 15;9(16):3328-36. doi: 10.4161/cc.9.16.12688. Epub 2010 Aug 16. Cell Cycle. 2010. PMID: 20703098 Free PMC article.

6

Oncogenic potential of BRAF versus RAS.

Benjamin CL, Ananthaswamy HN. Benjamin CL, et al. Among authors: ananthaswamy hn. Cancer Lett. 2008 Mar 18;261(2):137-46. doi: 10.1016/j.canlet.2007.10.033. Epub 2008 Feb 14. Cancer Lett. 2008. PMID: 18280030

7

Inhibition of UV-induced p53 mutations by sunscreens: implications for skin cancer prevention.

Ananthaswamy HN, Loughlin SM, Ullrich SE, Kripke ML. Ananthaswamy HN, et al. J Investig Dermatol Symp Proc. 1998 Aug;3(1):52-6. J Investig Dermatol Symp Proc. 1998. PMID: 9732059 Free article. Review.

8

Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation: relationship to skin cancer development.

Melnikova VO, Pacifico A, Chimenti S, Peris K, Ananthaswamy HN. Melnikova VO, et al. Among authors: ananthaswamy hn. Oncogene. 2005 Oct 27;24(47):7055-63. doi: 10.1038/sj.onc.1208863. Oncogene. 2005. PMID: 16007135

9

Inhibition of UV-induced p53 mutations and skin cancers by sunscreens: implication for skin cancer prevention.

Ananthaswamy HN, Ullrich SE, Kripke ML. Ananthaswamy HN, et al. Exp Dermatol. 2002;11 Suppl 1:40-3. doi: 10.1034/j.1600-0625.11.s.1.10.x. Exp Dermatol. 2002. PMID: 12444959

10

Inhibition of solar simulator-induced p53 mutations and protection against skin cancer development in mice by sunscreens.

Ananthaswamy HN, Ullrich SE, Mascotto RE, Fourtanier A, Loughlin SM, Khaskina P, Bucana CD, Kripke ML. Ananthaswamy HN, et al. J Invest Dermatol. 1999 May;112(5):763-8. doi: 10.1046/j.1523-1747.1999.00564.x. J Invest Dermatol. 1999. PMID: 10233769 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters